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Background: Uveitis sometimes causes hyphema, but severe hyphema as a complication following herpes zoster
uveitis has rarely been reported. We report a rare case of zoster sine herpete with unusually severe hyphema.
Case presentation: A 41-year-old Japanese female developed hyphema filling almost one-half of the depth of the
anterior chamber after a two-week history of unilateral anterior uveitis. Hyphema persisted for four weeks while sectorial
iris atrophy became gradually apparent. Systemic prednisolone and valaciclovir resulted in prompt resolution of uveitis
and hyphema. Serum anti-varicella zoster virus (VZV) IgG measured by enzyme immunoassay was 116 at presentation
and decreased to 20.3 four month later. In addition, the antibody level in aqueous humor was almost 10-fold higher
than that in serum examined 9 months after presentation. Because there was no skin lesion, this case was diagnosed
as zoster sine herpete. The patient underwent cataract operation due to secondary cataract. The final visual acuity in
decimal notation was 1.0, but complications such as severe iris atrophy, wide anterior synechiae, corneal opacity, and
decrease in corneal endothelial cell count remained.
Conclusion: Zoster sine herpete is an important differential diagnosis in a case of acute anterior uveitis with severe
hyphema, although such cases are quite rare. Measurement of anti-VZV IgG levels by enzyme immunoassay in aqueous
humor and serum would be useful in the diagnosis of VZV reactivation. Prompt diagnosis and administration of
corticosteroids and anti-herpes virus medication may improve the outcome.
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In this report, we present a case of acute anterior uveitis
with unusually severe hyphema. Not many cases of uveitis
develop hyphema. However, hyphema is known to develop
in some anterior uveitides including herpetic uveitis,
Fuchs heterochromic iridocyclitis, ankylosing spondylitis,
Reiter’s syndrome, and chronic uveitis with rubeosis,
although hyphema is mild in most cases [1,2].
Herpes zoster usually develops as reactivation of latent
varicella zoster virus (VZV) infection after chicken pox.
Typical herpes zoster involving the first branch of the
trigeminal nerve with skin lesions is called herpes zoster
ophthalmicus (HZO), whereas recurrence of herpes zoster
without skin lesions is known as zoster sine herpete
(ZSH). Herpes zoster uveitis may develop in both HZO
and ZSH. The common ocular manifestations in herpes
zoster uveitis are keratitis, iridocyclitis, and conjunctivitis* Correspondence: yoko-okunuki@nifty.com
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unless otherwise stated.[3]. Hyphema as a complication following herpes zoster
uveitis has been reported in a few cases [4,5], and severe
hyphema in only one case [5]. We report a rare case of
ZSH with severe hyphema diagnosed by serum and
aqueous humor levels of anti-VZV IgG.
Case presentation
A 41-year-old Japanese female was referred to our depart-
ment because of severe hyphema in the right eye for two
days, and anterior uveitis that had persisted for two weeks.
She had a history of chickenpox in early childhood, right
HZO without ocular involvement at 11 years of age, and
ovarian cyst. She had a headache and feeling of fatigue
starting at the onset of ocular symptoms.
At presentation, the best-corrected visual acuity (ex-
pressed in decimal scale) was counting finger at 30 cm
OD and 1.0 OS. Intraocular pressure was 8 mmHg OD
and 12 mmHg OS. Slit lamp examination of the right
eye revealed ciliary injection and severe hyphema filling
almost one-half of the depth of the anterior chamberl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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view of the fundus. However, no apparent abnormality
was detected in B-mode echo examination. There was
no rash on her face. She was receiving topical treatment
with 0.1% betamethasone, 1% atropine, and anti-glaucoma
agents, because intraocular pressure in the right eye was
30 mmHg when measured at the previous clinic before
hyphema developed. Routine blood tests showed no
abnormalities including blood cell counts, C-reactive
protein, immunoglobulins (IgG, IgA, and IgM), and
rheumatoid factor. Only anti-VZV IgG measured by
enzyme immunoassay (EIA) (negative: < 2.0) was elevated
to 116. Anti-herpes simplex virus IgG tested by EIA and
tuberculin skin test (Mantoux test) were negative. Carotid
ultrasound was performed to exclude the possibility
that hyphema was caused by ocular ischemia, but there
was no obstruction. There was no difference in blood
pressure measured in two arms, which would exclude
ocular ischemia caused by Takayasu disease. Since the
presence of anterior inflammation was evident at presen-
tation, subconjunctival injection of betamethasone (2 mg)
was given and the topical medications prescribed by the
former clinic were continued.
Two weeks after presentation, hyphema filling one-third
of the anterior chamber persisted. Acetazolamide (500 mg/
day) was started because intraocular pressure in the right
eye increased to 28 mmHg and subconjunctival injection
of betamethasone (2 mg) was given twice for persisting
anterior inflammation. Four weeks after presentation,
hyphema was approximately one-quarter of the depth.
Visibility of anterior chamber was improved, and segmen-
tal iris atrophy that is one of the characteristic ocular
manifestations of herpes zoster uveitis was visible. How-
ever, no facial skin lesion was observed. Detailed history
taking revealed that she had hypersensitivity at the
right forehead just before ocular symptoms appeared.
Therefore, ZSH was suspected.Figure 1 An anterior photograph taken at presentation. Prominent
hyphema is visible, with apparent ciliary injection. Detail of the iris is
not visible.Because anterior inflammation with ciliary injection
and hyphema with fresh bleeding from atrophic area of
the iris persisted, oral prednisolone (30 mg/day) and
valaciclovir (3000 mg/day) were started. After starting
these medications, ciliary injection improved and bleeding
from the iris stopped. Then prednisolone and valaciclovir
were gradually tapered. Oral medications were continued
for 6 weeks and stopped, when ciliary injection became
very mild and hyphema completely disappeared.
At three months after presentation, visual acuity was 0.9
OD, and ocular pressure was 9 mmHg OD and 17 mmHg
OS. Inflammation and hyphema were almost resolved
(Figure 2a). Ophthalmoscopic examination revealed 1+
cell in the anterior chamber, pigmented keratic precipitates,
segmental iris atrophy and posterior synechiae from 12 to 8
o’clock position, corneal opacity corresponding to the area
of iris atrophy, and broad anterior synechiae extending to
posterior cornea (Figure 2a-c). These observations were
consistent with herpes zoster uveitis. Also, cataract devel-
oped but fundus seemed to be normal. Topical medication
with 0.1% betamethasone was continued.
We then performed an anterior chamber paracentesis,
since hyphema was resolved. Multiplex polymerase chain
reaction (PCR) was conducted using the aqueous humor
sample to detect viruses including VZV, herpes simplex
virus, and cytomegalovirus. No viral DNA was detected.
However, serial measurements of serum anti-VZV IgG
showed a gradual decrease in level (Table 1). At 9 months
after presentation, we measured anti-VZV IgG level (EIA)
in aqueous humor and serum samples, and the levels
were 269 and 20.3, respectively (Table 1). ZSH was thus
confirmed.
There was no recurrence of severe inflammation, but
mild ciliary injection and a few cells in the anterior
chamber persisted, and cataract gradually increased in
severity. Twenty-two months after presentation, visual
acuity was hand motion at 30 cm due to cataract. The
patient underwent cataract operation. The surgery was
uneventful. Corneal endothelial cell count was 989/mm3
before surgery, and remained almost the same after surgery.
Visual acuity in the right eye improved to 1.0 after surgery.
However, intraocular pressure fluctuated between 5 and
30 mmHg after surgery, and macular edema developed
which was resolved by subtenon injection of triamcinolone.
Discussion
We encountered a case of acute anterior uveitis with severe
hyphema following ZSH in an immunocompetent woman.
Several complications resulted, such as severe iris atrophy,
decrease in corneal endothelial cell count, and secondary
cataract necessitating operation.
A definitive diagnosis of ZSH can be made by detecting
viral DNA in aqueous humor [6], but antibody examin-
ation is also useful in diagnosis [7]. In this case, PCR was
a b
c
Figure 2 Anterior and gonioscopic photographs taken three months after presentation, when inflammation and hyphema had almost
resolved. (a) Segmental iris atrophy and posterior synechiae from 12 to 8 o’clock position, and secondary cataract are apparent. Ciliary injection
is better depicted than at presentation. (b) Pigmented keratic precipitates are found in the inferior cornea. (c) A gonioscopic photograph of
inferonasal position. Broad anterior synechiae extends to posterior cornea.
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had almost resolved, and the result was negative. We
did not perform anterior chamber paracentesis while
hyphema was present to avoid aggravating the hyphema.
Delay of the procedure might be the reason that VZV-
DNA was not detected by PCR. We next attempted to
detect virus-specific antibody in the aqueous humor.
Even at 9 months after onset, anti-VZV IgG (EIA) in
the aqueous humor was approximately 10-fold higher
than the serum level. Because an antibody ratio equal
to or higher than 1.0 suggests local antibody production
[7], VZV was the probable cause of anterior uveitis. A
positive serum anti-VZV IgG test by EIA usually indicates
past VZV infection. The EIA is more sensitive and specific
than the complement fixation test for VZV [8]. In this
case, it was impossible to examine paired (acute and
convalescent) serum samples for IgG antibodies, because
the ocular disease had persisted for more than two weeks
when the patient presented. However, gradual decrease ofTable 1 Serial anti-VZV IgG levels in serum and level in
aqueous humor
VZV (IgG) EIA Sample





269 Aqueous humorserum anti-VZV IgG in 4 months (Table 1) after disease
onset strongly suggests that uveitis was caused by VZV.
The diagnostic approach of measuring anti-VZV IgG
(EIA) in the aqueous humor and serum is useful when
detection of viral DNA in aqueous humor by PCR is
negative, as in the present case. However, detection of
viral DNA in aqueous humor should remain the gold
standard for establishing a definitive diagnosis of ZSH [6].
On the other hand, the present diagnostic approach may
be superior to conventional paried serum test, because
it provides additional information of local production
of specific IgG in ocular tissues. However, IgG anti-
bodies do not reach high levels in the early phase of
disease. Therefore, the sensitivity of this method would
be low if peformed in the early phase of disease.
In most cases of uveitis with hyphema, the cause of
bleeding is supposed to be rubeosis [1]. In herpes zoster
uveitis, however, iris fluorescein angiography suggests
occlusive vasculitis to be the main pathogenesis of the
iris lesion causing bleeding [4,9]. The presence of rubeosis
cannot be excluded in the present case, because iris
fluorescein angiography was not performed, but marked
iris atrophy observed after resolution of inflammation
suggests the presence of severe inflammation that may
cause obstruction of iris vessels.
In the present case, the ocular condition improved sig-
nificantly after administration of systemic prednisolone
and valaciclovir. Prednisolone was used for the anti-
inflammatory effect and valaciclovir for suppression of
the reactivated VZV. We cannot deny that more prompt
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duced the complications such as secondary cataract,
decrease in corneal endothelial cell count, iris atrophy,
and corneal opacity.
Conclusions
We propose that ZSH is an important differential diagnosis
in a case of acute anterior uveitis with severe hyphema.
Serial measurements of serum anti-VZV IgG (EIA) and
simultaneous measurements of serum and aqueous
humor anti-VZV IgG (EIA) led to a diagnosis for VZV
reactivation. Especially in rare cases of severe anterior
inflammation with marked hyphema, laboratory tests
for a diagnosis of VZV activation and prompt systemic
administration of corticosteroids and anti-herpes virus
medication may improve the outcome.
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